Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NVNO · NASDAQ · Surgical & Medical Instruments & Apparatus
$5.25−0.32 (−5.75%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Envveno Medical (NVNO) · oqro.io/stocks/NVNO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 10, 2026
Thomas A. Satterfield, Jr. cut its NVNO stake below 5% (4.8%)SourceInsider trade · Traded Sep 15, 2025 · Filed Sep 17, 2025
Director sold ~$4.1K of NVNO shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 3, 2025
Director purchased ~$250K of NVNO shares in the open marketSourceInsider trade · Traded Dec 31, 2024 · Filed Jan 2, 2025
Director purchased ~$10K of NVNO shares in the open marketSourceInsider trade · Traded Dec 24, 2024 · Filed Dec 26, 2024
Director purchased ~$16K of NVNO shares in the open marketSourceInsider trade · Traded Dec 19, 2024 · Filed Dec 23, 2024
Director purchased ~$24K of NVNO shares in the open marketSourceInsider trade · Traded Dec 19, 2024 · Filed Dec 20, 2024
CEO purchased ~$31K of NVNO shares in the open marketSource